Application of Proteomic Strategy for the Identification of Differential Proteins Candidates to Biomarkers of Bipolar Disorder

  • Jemmyson Romário de JesusEmail author
Part of the Springer Theses book series (Springer Theses)


A comparative study using blood serum from individuals with BD, healthy individuals and individuals diagnosed with other psychiatric disorders, such as schizophrenia, was performed.


  1. 1.
    Araújo JE, Lodeiro C, Capelo JL, Rodriguez-Gonzàlez B, Santos A, Santos HM, Fernández-Lodeiro J (2015) Novel nanocomposites based on a strawberry-like gold-coated magnetite (Fe@Au) for protein separation in multiple myeloma serum samples. Nano Res 8(4):1189–1198CrossRefGoogle Scholar
  2. 2.
    Atkinson and Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95CrossRefGoogle Scholar
  3. 3.
    Chen J, Wang Y, Ding X, Huang Y, Xu K (2014) Analytical methods on hydroxy functional ionic liquid-modified magnetic nanoparticles. Anal Methods 6:8358–8367CrossRefGoogle Scholar
  4. 4.
    Chudal R, Sourander A, Polo-Kantola P, Hinkka-Yli-Salomaki S, Lehti V, Sucksdorff D, Gissler M, Brown AS (2014) Perinatal factors and the risk of bipolar disorder in finland. J Affect Disord 155:75–80CrossRefGoogle Scholar
  5. 5.
    Corrigan L, Browne J, Fitzgerald K, Chan GC, Kennely S, Marry J, Nash M, Ryan D, Ryan D, Fallon N, Steen G, Casey M, Walsh JB, Lee TC, Daly J (2011) 2D Dige as a strategy for identifying differentially expressed proteins in postmenopausal women with osteopenia and osteoporosis. Bone 48:194CrossRefGoogle Scholar
  6. 6.
    de Jesus JR, Campos BK, Galazzi RM, Martinez JL, Arruda MA (2015) Bipolar disorder : recent advances and future trends in bioanalytical developments for biomarker discovery. Anal Bioanal Chem 407:661–667Google Scholar
  7. 7.
    de Jesus JR, Pessôa GS, Sussulini A, Martinez JLC, Arruda MAZ (2016) Proteomics strategies for bipolar disorder evaluation: from sample preparation to validation. J Proteom 145:187–196CrossRefGoogle Scholar
  8. 8.
    de Jesus JR, Galazzi RM, Lima TB, Banzato CEM, Almeida Lima e Silva LF, Rosalmeida Dantas C, Gozzo FC, Arruda MAZ (2017a) Simplifying the human serum proteome for discriminating patients with bipolar disorder of other psychiatry conditions. Clin Biochem 50(18):1118–1125Google Scholar
  9. 9.
    de Jesus JR, Silva Fernades R, Souza Pessôa G, Raimundo IM Jr, Arruda MAZ (2017b) Depleting high-abundant and enriching low-abundant proteins in human serum: an evaluation of sample preparation methods using magnetic nanoparticle, chemical depletion and immunoaffinity techniques. Talanta 170:199–209Google Scholar
  10. 10.
    Dean B, Digney A, Sundram S, Thomas E, Scarr E (2008) Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder. Psychiatry Res 158(1):75–78CrossRefGoogle Scholar
  11. 11.
    Deng J, Yang Y, Wang X, Tiangang L (2014) Strategies for coupling solid-phase microextraction with mass spectrometry. Trac Trends in Analytical Chemistry 55:55–67CrossRefGoogle Scholar
  12. 12.
    Domon B, Aebersold R (2006) Mass spectrometry and protein analysis. Science 312(5771):212–217CrossRefGoogle Scholar
  13. 13.
    Fan NJ, Kang R, Ge XY, Li M, Liu Y, Chen HM, Gao CF (2014) Identification alpha-2-hs-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer. Diagn Pathol 9(53):1–11Google Scholar
  14. 14.
    Fernández-Costa C, Reboiro-Jato M, Fdez-Riverola F, Ruiz-Romero C, Blanco FJ, Martínez JLC (2014) Sequential depletion coupled to C18 sequential extraction as a rapid tool for human serum multiple profiling. Talanta 125:189–195CrossRefGoogle Scholar
  15. 15.
    Fulford D, Peckham AD, Johnson K, Johnson S (2014) Emotion perception and quality of life in bipolar disorder. J Affect Disord 152–154:491–497CrossRefGoogle Scholar
  16. 16.
    Geoffroy PA, Boudebesse C, Bellivier F, Lajnef M, Henry C, Leboyer M, Scott J, Etain B (2014) Sleep in remitted bipolar disorder: a naturalistic case-control study using actigraphy. J Affect Disord 158:1–7CrossRefGoogle Scholar
  17. 17.
    Giusti L, Mantua V, Da Valle Y, Ciregia F, Ventroni T, Orsolini G, Donadio E, Giannaccini G, Mauri M, Cassano GB, Lucacchini A (2014) Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach. Mol BioSyst 10(6):1246–1254CrossRefGoogle Scholar
  18. 18.
    Herberth M, Koethe D, Levin Y, Schwarz E, Krzyszton ND, Schoeffmann S, Ruh H, Rahmoune H, Kranaster L, Schoenborn T, Leweke MF, Guest PC, Bahn S (2011) Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival. Proteomics 11(1):94–105CrossRefGoogle Scholar
  19. 19.
    Hilty DM, Leamon MH, Lim RF, Kelly RH, Hales RE (2006) A review of bipolar disorder in adults. Psychiatry 3(9):43–55PubMedGoogle Scholar
  20. 20.
    Hu Z, Zhang H, Zhang Y, Wu R, Zou H (2014) Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles. Colloids Surf B 121:354–361CrossRefGoogle Scholar
  21. 21.
    Huang JTJ, Leweke FM, Oxley D, Wang L, Harris N, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Reed B, Bahn S (2006) Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. Plos Med 3(1.1):2145–2158Google Scholar
  22. 22.
    Iavarone F, Mellis M, Platania G, Cabras T, Manconi B, Petruzzelli R, Cordaro M, Siracusano A, Faa G, Messana I, Zanasi M, Castagnola M (2014) Characterization of salivary proteins of schizophrenic and bipolar disorder patients by top-down proteomics. J Proteom 103:15–22CrossRefGoogle Scholar
  23. 23.
    Javanmard M, Emaminejad S, Gupta C, Provine J, Davis RW, Howe RT (2014) Sensors and actuators B: chemical depletion of cells and abundant proteins from biological samples by enhanced dielectrophoresis. Sens Actuators B Chem 193:918–924CrossRefGoogle Scholar
  24. 24.
    Jessen F, Wulff T (2015) Triton x-114 cloud point extraction to subfractionate blood plasma proteins for two-dimensional gel electrophoresis. Anal Biochem 485:1–7CrossRefGoogle Scholar
  25. 25.
    Kay R, Barton C, Ratcliffe L, Matharoo-Ball B, Brown P, Roberts J (2008) Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis. Rapid Commun Mass Spectrom 22:3255–3260CrossRefGoogle Scholar
  26. 26.
    Kinter M, Sherman NE (2000) Protein sequencing and identification using tandem mass spectrometry. Wiley, New York, pp 29–63.
  27. 27.
    Kurdal E, Tanriverdi D, Savas HA (2014) The effect of psychoeducation on the functioning level of patients with bipolar disorder. West J Nurs Res 36(3):312–328CrossRefGoogle Scholar
  28. 28.
    Leboyer M, Soreca I, Scott J, Frye M, Henry C, Tamouza R, Kupfer DJ (2012) Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disorders 141(1):1–10Google Scholar
  29. 29.
    Li F, Seillier-Moiseiwitsch F, Korostyshevskiy VR (2011) Region-based statistical analysis of 2d page images. Comput Stat Data Anal 55(11):3059–3072CrossRefGoogle Scholar
  30. 30.
    Lu AH, Salabas EL, Schüth F (2007) Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angewandte Chemie - International Edition 46(8):1222–1244CrossRefGoogle Scholar
  31. 31.
    Mantini D, Petrucci F, Del Boccio P, Pieragostino D, Di Nicola M, Lugaresi A, Federici G, Sacchetta P, Di Llio C, Urbani A (2008) Independent component analysis for the extraction of reliable protein signal profiles from maldi-tof mass spectra. Bioinformatics 24(1):63–70CrossRefGoogle Scholar
  32. 32.
    Marmol F (2008) Lithium: bipolar disorder and neurodegenerative diseases possible cellular mechanisms of the therapeutic effects of lithium. Prog Neuropsychopharmacol Biol Psychiatry 32(8):1761–1771CrossRefGoogle Scholar
  33. 33.
    Matsumoto J, Sugiura Y, Yuki D, Hayasaka T, Goto-Inoue N, Zaima N, Kunii Y, Wada A, Yang Q, Nishiura K, Hashizume Y, Yamamoto T, Ikemoto K, Setou M, Niwa S (2011) Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption/ionization imaging mass spectrometry. Anal Bioanal Chem 400:1933–1943Google Scholar
  34. 34.
    Moraes MCB, Lago CL (2003) Espectrometria de massas com ionização por “electrospray” aplicada ao estudo de espécies inorgânicas e organometálicas. Quim Nova 26(4):556–563CrossRefGoogle Scholar
  35. 35.
    Patel S (2012) Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges. Expert Rev Proteom 9:249–265CrossRefGoogle Scholar
  36. 36.
    Peng ZG, Hidajat K, Uddin MS (2004) Adsorption of bovine serum albumin on nanosized magnetic particles. J Colloid Interface Sci 271(2):277–283CrossRefGoogle Scholar
  37. 37.
    Rabilloud T, Lelong C (2011) Two-dimensional gel electrophoresis in proteomics: a tutorial. J Proteom 74(10):1829–1841CrossRefGoogle Scholar
  38. 38.
    Redpath HL, Cooper D, Lawrie SM (2013) Imaging symptoms and syndromes: similarities and differences between schizophrenia and bipolar disorder. Biol Psychiat 73(6):495–496CrossRefGoogle Scholar
  39. 39.
    Renner J, Almeida C, Phillips ML (2012) Distinguishing between unipolar depression and bipolar depression: current and future clinical and neuroimaging perspectives. Biol Psychiat 73(2):111–118Google Scholar
  40. 40.
    Rico Santana N, Muniz EZ, Cocho D, Bravo Y, Mederos RD, Marti-Fábregas J (2014) Analysis of peptidome profiling of serum from patients with early onset symptoms of ischemic stroke. J Stroke Cerebrovasc Dis 23(2):235–240CrossRefGoogle Scholar
  41. 41.
    Roche S, Tiers L, Provansai M, Seveno M, Piva MT, Jouin P, Lehmann S (2009) Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: the more the better? J Proteom 72(6):945–951CrossRefGoogle Scholar
  42. 42.
    Sokolowska I, Ngounou AG (2013) The potential of biomarkers in psychiatry: focus on proteomics. J Neural Transm 122:1–9Google Scholar
  43. 43.
    Sussulini A, Prando A, Maretto DA, Poppi RJ, Tasic L, Banzato CEM, Arruda MAZ (2009) Metabolic profiling of human blood serum from H NMR spectroscopy and chemometrics. Anal Chem 81(23):9755–9763CrossRefGoogle Scholar
  44. 44.
    Sussulini A, Dihazi H, Banzato CE, Arruda MA, Stuhmer W, Ehrenreich H, Jahn O, Kratzin HD (2011a) Apolipoprotein AI as a candidate serum marker for the response to lithium treatment in bipolar disorder. Proteomics 11(2):261–269Google Scholar
  45. 45.
    Sussulini A, Banzato CEM, Arruda MAZ (2011) Exploratory analysis of the serum ionomic profile for bipolar disorder and lithium treatment. Int J Mass Spectrom 307(1–3):182–184CrossRefGoogle Scholar
  46. 46.
    Timerbaev A, Pawlak K, Gabbiani C, Messori L (2011) Recent progress in the application of analytical techniques to anticancer metallodrug proteomics. TrAC Trends Anal Chem 30(7):1120–1138CrossRefGoogle Scholar
  47. 47.
    Tonge R, Shaw J, Middleton B, Rowlinson R, Rayner S, Young J, Pognan F, Hawkins E, Davison M (2001) Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1(3):377–396Google Scholar
  48. 48.
    Von thun und hohenstein-blaul N, Funke S, Grus FH (2013) Tears as a source of biomarkers for ocular and systemic diseases. Experim Eye Res 117:126–137Google Scholar
  49. 49.
    Warder SE, Tucker LA, Strelitzer TJ, Mckeegan EM, Meuth JL, Jung PM, Saraf A, Singh B, Lai-Zhang J, Gagne G, Rogers JC (2009) Reducing agent-mediated precipitation of high-abundance plasma proteins. Anal Biochem 387(2):184–193CrossRefGoogle Scholar
  50. 50.
    Yang ST, Liu Y, Wang YW, Cao A (2013) Biosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactions. Small 9(9–10):1635–1653CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Institute of ChemistryUniversity of CampinasCampinasBrazil

Personalised recommendations